Suzhou Fengbei Biotech Stock Co., Ltd.

603334 · SHG · Industrials / Waste Management

25.52CNY-0.60 (-2.30%)

Price History

Full chart

Market Stats

Previous Close26.12

Open26.14

Day Range25.42 – 26.47

52-Week Range24.73 – 60.48

Volume997.31K

Market Cap3.93B

P/E (TTM)28.80

Forward P/E0.00

EPS0.95

Dividend Yield1.28%

50-Day Avg30.59

200-Day Avg41.04

About

Suzhou Fengbei Biotech Stock Co., Ltd. manufactures and sells resource-based products from utilization of waste resources in China. It offers bio-based materials for use in pesticides, fertilizers, mineral processing, ink resins, textiles, biopharmaceuticals, and other fields; biofuels; and oleochemicals, such as DD oil, fatty acids. The company was incorporated in 2014 and is based in Zhangjiagang, China.

Company Details

SectorIndustrials
IndustryWaste Management
CEOMr. Yin Li
Employees395
HeadquartersNo. 1 Donghai Road, Zhangjiagang, China, 215600, China
Websitehttps://www.sz-fb.cn

Leadership

Mr. Yin LiGM & Director · b. 1986
Mr. Ya Zhou GuFinancial Director · b. 1985
Ms. Min MaTechnical Director · b. 1983
Ms. Guo Lin WuMarketing Director · b. 1981
Mr. Yi Yong WangProduction Director & Director · b. 1977
Mr. Jiang HuangDeputy GM & Secretary of the Board · b. 1979
Min Juan ShenDeputy CFO & Head of Accounting Department

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.29B	1.70B	1.72B	-	3.17B
Growth (%)	-	+32.05%	+1.15%	-	-
Cost of Revenue	1.11B	1.48B	1.49B	-	2.91B
Gross Profit	182.90M	219.04M	227.03M	-	258.92M
Gross Margin	14.19%	12.87%	13.19%	-	8.17%
Operating Expense	74.89M	89.17M	110.74M	-	91.57M
Operating Income	108.01M	129.87M	116.29M	-	167.34M
Operating Margin	8.38%	7.63%	6.75%	-	5.28%
EBITDA	122.74M	164.12M	172.76M	166.02M	191.80M
EBITDA Margin	9.52%	9.64%	10.03%	-	6.05%
Net Income	101.91M	133.35M	129.71M	-	140.55M
Net Income Margin	7.91%	7.83%	7.53%	-	4.43%
R&D	40.90M	50.38M	57.46M	-	68.18M
R&D as % of Total Revenue	3.17%	2.96%	3.34%	-	2.15%
Interest Expense	3.79M	6.90M	7.94M	12.00M	7.69M
Interest Expense % of Total Revenue	0.29%	0.41%	0.46%	-	0.24%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2025-12-31
Total Assets	599.09M	937.82M	1.05B	2.23B
Total Liabilities	214.30M	422.38M	410.04M	525.60M
Total Equity	380.77M	513.42M	629.50M	1.70B
Cash	84.48M	217.73M	156.74M	567.16M
Total Debt	143.29M	283.06M	267.35M	-
Net Debt	58.81M	65.32M	110.61M	-

Cash Flow

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2025-12-31
Operating Cash Flow	77.51M	69.72M	162.50M	-26.44M
Investing Cash Flow	-72.97M	-87.14M	-167.41M	-
Financing Cash Flow	35.79M	98.01M	-26.20M	-
Capital Expenditure	71.94M	80.10M	168.11M	24.36M
Free Cash Flow	5.57M	-10.38M	-5.62M	-50.80M
Dividends Paid	-	-	-	10.35M
FCF to OCF	7.18%	-14.89%	-3.46%	192.13%
Dividend Paid to FCF	-	-	-	-20.37%

Key Statistics & Ratios

Market Cap3.93B

Enterprise Value3.49B

Trailing P/E28.80

Forward P/E0.00

Price / Sales0.89

Price / Book2.23

EPS0.95

Book Value12.26

Revenue (TTM)4.40B

Gross Profit (TTM)278.14M

EBITDA204.50M

Profit Margin3.04%

Operating Margin3.76%

Return on Equity10.14%

Return on Assets5.64%

Shares Outstanding143.50M

Shares Float44.52M

Dividend Yield1.28%

Dividend Rate0.35

Payout Ratio36.92%